News
Enceph-IG Trial - care centres needed
12 December 2023
Enceph-IG Trial: Intravenous Immunoglobulin (IVIG) in Autoimmune Encephalitis in Adults –A Randomised Double-Blind Placebo-Controlled Trial Can you help? Researchers are seeking secondary or tertiary care centres to help a trial establish whether with intravenous immunoglobulin improves recovery in adults with autoimmune encephalitis. Enceph-IG is a phase III, double blind, randomised placebo control trial lead by […]
Read MoreUnveiling the Global Vision of Encephalitis International
11 December 2023
After extensive collaboration with our key stakeholders, we are thrilled to unveil a significant chapter in our journey. We have renamed our non-profit organisation to Encephalitis International; a strategic evolution that mirrors our renewed commitment to saving lives on a global scale. Understanding the Urgency The emergence of new pathogens, or existent pathogens in […]
Read More
BBC Radio 4 appeal
8 December 2023
BBC Radio Four has chosen Encephalitis International to be featured on its 2021 charity appeal on Boxing Day and the 30th December. Find out more – and hear from our presenter, author Catherine Jessop. We will be broadcast live on: Sunday, 26th December: 7.54am and 9.45pm Thursday, 30th December: 3.27pm Listen to the BBC Appeal (available […]
Read More
£2.3m study to investigate COVID-19 effects
8 December 2023
A grant worth £2.3 million pounds has been awarded to clinical researchers from the University of Liverpool and King’s College London to investigate the neurological and neuropsychiatric effects of COVID-19. The COVID-19 Clinical Neuroscience Study (COVID-CNS) will look at 800 UK patients who were admitted to hospital with COVID-19 and had neurological or neuropsychiatric […]
Read More